Wellington Management Group
CNST

Wellington Management Group’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Wellington Management Group’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-933,294
Closed -$31.5M – 2355
2021
Q2 		$31.5M Sell
933,294
-3,470,835
-79% -$88.4M 0.01% 978
2021
Q1 		$103M Buy
4,404,129
+9,586
+0.2% +$290K 0.02% 609
2020
Q4 		$127M Sell
4,394,543
-4,969
-0.1% -$125K 0.02% 527
2020
Q3 		$89.1M Sell
4,399,512
-1,253
-0% -$30.6K 0.02% 549
2020
Q2 		$132M Buy
4,400,765
+2,058,533
+88% +$74.1M 0.03% 456
2020
Q1 		$73.6M Buy
2,342,232
+396,604
+20% +$13.8M 0.02% 531
2019
Q4 		$91.7M Buy
+1,945,628
New +$56.2M 0.02% 594

Wellington Management Group's CNST Position: Q3 2021 in Review

Wellington Management Group sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 933,294 shares — an estimated $31.5M sold.

Wellington Management Group first reported a position in CNST in Q4 2019 and held it in 7 quarters. The position peaked at $132M in Q2 2020. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Wellington Management Group reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Wellington Management Group sold 933,294 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $31.5M.
  • Wellington Management Group first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 7 quarters.
  • Wellington Management Group's Constellation Pharmaceuticals, Inc. position peaked at $132M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Wellington Management Group's 13F filing for Q3 2021, filed 15 Nov 2021.